schizandrin has been researched along with Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aras, A; Attar, R; Butt, G; Farooqi, AA; Lin, X; Mobeen, I; Yulaevna, IM | 1 |
| Acharekar, N; Alagaratnam, A; Kong, J; Yoganathan, S | 1 |
2 review(s) available for schizandrin and Neoplasms
| Article | Year |
|---|---|
Regulation of cell signaling pathways by Schisandrin in different cancers: Opting for "Swiss Army Knife" instead of "Blunderbuss".
Topics: Animals; Apoptosis; Carcinogenesis; Cell Movement; Clinical Trials as Topic; Cyclooctanes; Gene Expression Regulation, Neoplastic; Humans; Lignans; Neoplasms; Plant Extracts; Polycyclic Compounds; Protein Interaction Maps; Schisandra; Signal Transduction; Treatment Outcome | 2021 |
Ellagic Acid and Schisandrins: Natural Biaryl Polyphenols with Therapeutic Potential to Overcome Multidrug Resistance in Cancer.
Topics: Animals; Cyclooctanes; Drug Discovery; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Ellagic Acid; Humans; Lignans; Neoplasms; Polycyclic Compounds; Polyphenols | 2021 |